Not Signed In -
Ischemic Heart Disease |
|
|
Clinical Trial: DANish Multicenter STENT Trial
This study has been completed.
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| Ischemic Heart Disease Stable angina Unstable Angina | Device: Coronary Stent Implantation | Phase IV |
MedlinePlus related topics: Angina; Coronary Disease; Heart Diseases; Vascular Diseases
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: Low Restenosis Rate of the NIR Coronary Stent: Results of the Danish Multicenter Stent Study (DANSTENT) – a Randomized Study Comparing a First-Generation with a Second-Generation Stent.
Expected Total Enrollment: 400
Study start: April 1997; Study completion: January 2006
Last follow-up: June 2001; Data entry closure: July 2001
Eligibility
Inclusion Criteria:
- Stable, unstable or silent angina,
- De novo lesion
Exclusion Criteria:
- Allergy to ticlopidine
- Recent myocardial infarction
- Expected survival > 1 year
Location Information
Denmark
Rigshospitalet, Copenhagen, DK-2100, Denmark
Henning Kelbaek, MD, Principal Investigator, Rigshospitalet, Copenhagen
More Information
Publications that report results of this study
Jorgensen E, Kelbaek H, Helqvist S, Jensen GV, Saunamaki K, Kastrup J, Madsen JK, Klovgaard L, Thuesen L, Villadsen A, van Weert AW, Reiber JH; Danish multicenter stent study (DANSTENT). Low restenosis rate of the NIR coronary stent: results of the Danish multicenter stent study (DANSTENT)--a randomized trial comparing a first-generation stent with a second-generation stent. Am Heart J. 2003 Feb;145(2):e5.
Last Updated: August 30, 2005
Record first received: August 30, 2005
ClinicalTrials.gov Identifier: NCT00139802
Health Authority: Denmark: National Board of Health
ClinicalTrials.gov processed this record on 2005-09-13
Resources
- What Is Coronary Artery Disease? (National Heart, Lung and Blood Institute)
email this page
print this page
bookmark this page
feedback on this page
